Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interplay between Furin and Sialoglycans in Modulating Adeno-Associated Viral Cell Entry. | J Virol | 2023 | 37097176 | PubTator, text mining | PubMed |
| The human E3 ligase RNF185 is a regulator of the SARS-CoV-2 envelope protein. | iScience | 2023 | 37095859 | PubTator, text mining | PubMed |
| Zika virus-induces metabolic alterations in fetal neuronal progenitors that could influence in neurodevelopment during early pregnancy. | Biol Open | 2023 | 37093064 | PubTator, text mining | PubMed |
| An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies. | AIMS Microbiol | 2023 | 37091823 | PubTator, text mining | PubMed |
| Virus-host Interactions in Early Japanese Encephalitis Virus Infection. | Virus Res | 2023 | 37086856 | PubTator, text mining | PubMed |
| Therapeutic strategies for COVID-19: progress and lessons learned. | Nat Rev Drug Discov | 2023 | 37076602 | PubTator, text mining | PubMed |
| Expression and purification of MERS-CoV envelope protein, an essential viroporin, using the baculovirus expression system. | Iran J Microbiol | 2023 | 37069902 | PubTator, text mining | PubMed |
| Seasonal effects decouple SARS-CoV-2 haplotypes worldwide. | F1000Res | 2023 | 37069849 | PubTator, text mining | PubMed |
Effect Analysis of Different Environmental Disinfection Methods on Reducing Contamination of Surfaces by the Omicron BA.2.2 Variant of SARS-CoV-2 and the Characteristics of Fomite Contamination in the Fever Clinic in the Out-Broken of Shanghai. | Food Environ Virol | 2023 | 37067719 | PubTator, text mining | PubMed |
| Potential treatments of COVID-19: Drug repurposing and therapeutic interventions. | J Pharmacol Sci | 2023 | 37059487 | PubTator, text mining | PubMed |
| Integrated systems immunology approach identifies impaired effector T cell memory responses as a feature of progression to severe dengue fever. | J Biomed Sci | 2023 | 37055751 | PubTator, text mining | PubMed |
| Exploring potential SARS-CoV-2 Mpro non-covalent inhibitors through docking, pharmacophore profile matching, molecular dynamic simulation, and MM-GBSA. | J Mol Model | 2023 | 37055578 | PubTator, text mining | PubMed |
| Porcine Epidemic Diarrhea Virus Antagonizes Host IFN-λ-Mediated Responses by Tilting Transcription Factor STAT1 toward Acetylation over Phosphorylation To Block Its Activation. | mBio | 2023 | 37052505 | PubTator, text mining | PubMed |
| Roles of p53-Mediated Host-Virus Interaction in Coronavirus Infection. | Int J Mol Sci | 2023 | 37047343 | PubTator, text mining | PubMed |
| Mechanism of inert inflammation in an immune checkpoint blockade-resistant tumor subtype bearing transcription elongation defects. | Cell Rep | 2023 | 37043352 | PubTator, text mining | PubMed |
| COVID-19 in early 2023: Structure, replication mechanism, variants of SARS-CoV-2, diagnostic tests, and vaccine & drug development studies. | MedComm (2020) | 2023 | 37041762 | PubTator, text mining | PubMed |
| Chicken-origin Cluster 3.2 Tembusu virus exhibits higher infectivity than duck-origin Cluster 2 Tembusu virus in chicks. | Front Vet Sci | 2023 | 37035806 | PubTator, text mining | PubMed |
| Biomolecular condensates: insights into early and late steps of the HIV-1 replication cycle. | Retrovirology | 2023 | 37029379 | PubTator, text mining | PubMed |
| Next-generation nanophotonic-enabled biosensors for intelligent diagnosis of SARS-CoV-2 variants. | Sci Total Environ | 2023 | 37028663 | PubTator, text mining | PubMed |
| Correlation between the IgG/IgA Antibody Response against PEDV Structural Protein and Virus Neutralization. | Microbiol Spectr | 2023 | 37022185 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=25